Mergers & Acquisitions - Biotechnology

Filter

Current filters:

Biotechnology

Popular Filters

176 to 200 of 255 results

Human Genome capitulates, accepting raised offer from GlaxoSmithKline

17-07-2012

Confirming weekend rumors (The Pharma Letter July 16), UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

BB Biotech rejects privatization proposal by Vontobel Group

16-07-2012

Swiss biotechnology investment fund BB Biotech (SIX: BION) has confirmed that Vontobel Group has made…

BB BiotechBiotechnologyEuropeFinancialMergers & AcquisitionsVontobel

Grifols acquires 40% of Spanish biotech firm VCN Bioscience

16-07-2012

Spanish health care group Grifols (GRLS: MC), the world's third largest plasma product manufacturer,…

BiotechnologyGrifolsMergers & AcquisitionsOncologyVCN Bioscience

Spectrum extends tender offer for Allos

09-07-2012

US biotech firm Spectrum Pharmaceuticals (Nasdaq: SPPI) said late Friday that it has again extended tender…

Allos TherapeuticsBiotechnologyFolotynMergers & AcquisitionsOncologySpectrum Pharmaceuticals

Bilthoven Biologicals acquired by Serum Institute of India

06-07-2012

Bilthoven Biologicals, a Dutch manufacturer of monoclonal antibodies and vaccines, said this week that…

Bilthoven BiologicalsBiotechnologyMergers & AcquisitionsPharmaceuticalSerum Institute of IndiaVaccines

GlaxoSmithKline $2.6 billion tender offer for Human Genome Sciences saga continues

02-07-2012

Continuing its attempts to gain control of its development partner Human Genome Sciences (Nasdaq: HGSI),…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Theradiag acquires Prestizia and its MicroRNA technology platform

28-06-2012

Theradiag, (previously Biomedical Diagnostics), a Paris, France-based theranostics and in vitro diagnostics…

BiotechnologyMergers & AcquisitionsPrestiziaTheradiag

Compugen and Merck Serono set up biomarker company Neviah Genomics

25-06-2012

German drug major Merck KGaA's (MRK: DE) Merck Serono division and Israel-based Compugen (Nasdaq: CGEN)…

BiotechnologyCompugenMerck KGaAMerck SeronoMergers & AcquisitionsResearch

XTL Biopharma to acquire Kitov Pharmaceuticals

21-06-2012

Israeli biopharma firm XTL Biopharmaceuticals (TASE:XTL) says it will acquire fellow Israel-based Kitov…

BiotechnologyKitov PharmaceuticalsMergers & AcquisitionsPharmaceuticalXTL Biopharmaceuticals

Human Genome Sciences sets July 16 deadline for takeover bids

18-06-2012

In the latest update on UK pharma giant GlaxoSmithKline's (LSE: GSK) hostile takeover attempts for Human…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Pharming considers options, including a sale of the company

13-06-2012

Netherland-based biotech company Pharming Group (NYSE Euronext: PHARM) yesterday revealed that it is…

BiotechnologyLicensingMergers & AcquisitionsPharmingRare diseasesResearchRuconest

Zacks analysts view progress of GSK bid for Human Genome Sciences

05-06-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) recently announced that the waiting period with respect to…

BenlystaBiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

NicOx drops its option to take full ownership of Altacor

04-06-2012

French biotechnology firm NicOx (NYSE Euronext Paris: COX) said last Friday that its board of directors…

AltacorBiotechnologyMergers & AcquisitionsNicOxOphthalmics

Sanofi's Aubagio reduces MS relapse; firm aims to build diabetes portfolio

01-06-2012

Genzyme, a subsidiary of French drug major Sanofi (Euronext: SAN) today reported top-line results from…

AubagioBiotechnologyDiabetesGenzymeMergers & AcquisitionsNeurologicalPharmaceuticalResearchSanofiteriflunomide

Israel's Thrombotech and D-Pharm to merge

25-05-2012

intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical…

BiotechnologyD-PharmHadasit Bio-HoldingsMergers & AcquisitionsThrombotech

French biotechnology a sector in need of new growth solutions

23-05-2012

The biotechnology industry in France is a dynamic sector mainly made up of small structures, but companies…

BiotechnologyEuropeFinancialMergers & Acquisitions

InterMune to divest Actimmune for $55 million; to focus on Esbriet

22-05-2012

California, USA-based biotech firm InterMune (Nasdaq: ITMN) says that it has reached a definitive agreement…

ActimmuneBiotechnologyEsbrietFinancialImmunologicalsInterMuneMergers & AcquisitionsRespiratory and PulmonaryVidara Therapeutics

Human Genome adopts Rights Plan to thwart GSK hostile takeover

18-05-2012

US biotech company Human Genome Sciences (Nasdaq: HGSI) said yesterday that, after carefully reviewing…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

GlaxoSmithKline buys full control of Cellzome

16-05-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) has signed an agreement to fully acquire privately held Cambridge…

BiotechnologyCellzomeGlaxoSmithKlineMergers & AcquisitionsPharmaceutical

Amylin said to be attracting several Big Pharma suitors

16-05-2012

US biotech firm Amylin Pharmaceuticals (Nasdaq: AMLN), which earlier this year rebuffed a $22 per share…

AmylinAstraZenecaBiotechnologyBristol-Myers SquibbMerck & CoMergers & AcquisitionsPfizerPharmaceuticalRocheSanofiTakeda Pharmaceuticals

176 to 200 of 255 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top